27th May 2015 09:09
LONDON (Alliance News) - Cambridge Cognition Holdings PLC Wednesday said its performance remains in line with market expectations in a statement ahead of its annual general meeting.
According to Morningstar, FinnCap expects Cambridge Cognition to post a pretax profit of GBP300,000 for 2015.
The company said that contributions from its clinical trials and academic businesses continued to grow in its first quarter, and its enlarged US sales team have helped secure a "healthy pipeline" of contracts in the safety and tolerability trial space that it expects to convert over the remainder of the year.
"The return to profitability in our clinical trials and academic businesses enables us to increase investment in our early stage healthcare technology business which bodes well for the future prospects of the company," said Chief Executive Officer Nick Kerton in the statement.
Shares in Cambridge Cognition are untraded Wednesday morning. It last closed at 75.60 pence.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Cambridge Cog